Discovery and validation of methylation markers for endometrial cancer
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
The prognosis of endometrial cancer is strongly associated with stage at diagnosis, suggesting that early detection may reduce mortality. Women who are diagnosed with endometrial carcinoma often have a lengthy history of vaginal bleeding, which offers an opportunity for early diagnosis and curative treatment. We performed DNA methylation profiling on population-based endometrial cancers to identify early detection biomarkers and replicated top candidates in two independent studies. We compared DNA methylation values of 1,500 probes representing 807 genes in 148 population-based endometrial carcinoma samples and 23 benign endometrial tissues. Markers were replicated in another set of 69 carcinomas and 40 benign tissues profiled on the same platform. Further replication was conducted in The Cancer Genome Atlas and in prospectively collected endometrial brushings from women with and without endometrial carcinomas. We identified 114 CpG sites showing methylation differences with p values of ≤ 10(-7) between endometrial carcinoma and normal endometrium. Eight genes (ADCYAP1, ASCL2, HS3ST2, HTR1B, MME, NPY and SOX1) were selected for further replication. Age-adjusted odds ratios for endometrial cancer ranged from 3.44 (95%-CI: 1.33-8.91) for ASCL2 to 18.61 (95%-CI: 5.50-62.97) for HTR1B. An area under the curve (AUC) of 0.93 was achieved for discriminating carcinoma from benign endometrium. Replication in The Cancer Genome Atlas and in endometrial brushings from an independent study confirmed the candidate markers. This study demonstrates that methylation markers may be used to evaluate women with abnormal vaginal bleeding to distinguish women with endometrial carcinoma from the majority of women without malignancy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Renehan, A. G., Tyson, M., Egger, M., Heller, R. F., & Zwahlen, M. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60269-x · Cited by 5,219
Evaluation of DNA from the Papanicolaou test to detect ovarian and endometrial cancers.
Kinde, I., Bettegowda, C., Wang, Y., Wu, J., Agrawal, N., Shih, I.-M., Kurman, R., Dao, F., Levine, D. A., Giuntoli, R., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3004952 · Cited by 327
Prediction models in women with postmenopausal bleeding: a systematic review.
van Hanegem, N., Breijer, M. C., Opmeer, B. C., Mol, B. W., & Timmermans, A. (2012) · Women's Health · doi:10.2217/whe.12.10 · Cited by 12 · cited 3×
“Conversely, abnormal vaginal bleeding is an extremely common complaint that is unrelated to carcinoma in the substantial majority of women.(7) Thus, distinguishing the minority of women who require management for carcinoma precursors or carcinoma from others with benign causes of abnormal Key words: endometrial cancer…”
BackgroundInfluential
Research works printed but not linked: 33
- Wright, 2012, Contemporary management of endometrial cancer, Lancet, 379, 1352, 10.1016/S0140-6736(12)60442-5 · DOI · Paper page
- Kosary, 2007, SEER survival monograph: cancer survival among adults
- Lacey, 2008, Endometrial carcinoma risk among women diagnosed with endometrial hyperplasia: the 34-year experience in a large health plan, Br J Cancer, 98, 45, 10.1038/sj.bjc.6604102 · DOI · Paper page
- Lacey, 2010, Absolute risk of endometrial carcinoma during 20-year follow-up among women with endometrial hyperplasia, J Clin Oncol, 28, 788, 10.1200/JCO.2009.24.1315 · DOI · Paper page
- van Hanegem, 2011, Diagnostic evaluation of the endometrium in postmenopausal bleeding: an evidence-based approach, Maturitas, 68, 155, 10.1016/j.maturitas.2010.11.010 · DOI
- Sherman, 2008, Reproducibility of biopsy diagnoses of endometrial hyperplasia: evidence supporting a simplified classification, Int J Gynecol Pathol, 27, 318, 10.1097/PGP.0b013e3181659167 · doi:10.1097/pgp.0b013e3181659167
- Trimble, 2006, Concurrent endometrial carcinoma in women with a biopsy diagnosis of atypical endometrial hyperplasia: a Gynecologic Oncology Group study, Cancer, 106, 812, 10.1002/cncr.21650 · DOI · Paper page
- Trimble, 2012, Management of endometrial precancers, Obstet Gynecol, 120, 1160, 10.1097/AOG.0b013e31826bb121 · DOI · Paper page
- Bach, 2002, Survival of blacks and whites after a cancer diagnosis, JAMA, 287, 2106, 10.1001/jama.287.16.2106 · DOI · Paper page
- Gallicchio, 2005, Fear of cancer among women undergoing hysterectomy for benign conditions, Psychosom Med, 67, 420, 10.1097/01.psy.0000160472.69303.56 · DOI
- Jiang, 2008, Application of DNA methylation biomarkers for endometrial cancer management, Expert Rev Mol Diagn, 8, 607, 10.1586/14737159.8.5.607 · DOI
- Kandoth, 2013, Integrated genomic characterization of endometrial carcinoma, Nature, 497, 67, 10.1038/nature12113 · DOI · Paper page
- Zhou, 2007, Epigenetic considerations for endometrial cancer prevention, diagnosis and treatment, Gynecol Oncol, 107, 143, 10.1016/j.ygyno.2007.06.019 · DOI
- Brinton, 2007, Reproductive risk factors for endometrial cancer among Polish women, Br J Cancer, 96, 1450, 10.1038/sj.bjc.6603731 · DOI
- Kipp, 2008, Direct uterine sampling with the Tao brush sampler using a liquid-based preparation method for the detection of endometrial cancer and atypical hyperplasia: a feasibility study, Cancer, 114, 228, 10.1002/cncr.23636 · DOI
- Bibikova, 2009, GoldenGate assay for DNA methylation profiling, Methods Mol Biol, 507, 149, 10.1007/978-1-59745-522-0_12 · DOI · Paper page
- Killian, 2009, Large-scale profiling of archival lymph nodes reveals pervasive remodeling of the follicular lymphoma methylome, Cancer Res, 69, 758, 10.1158/0008-5472.CAN-08-2984 · DOI · Paper page
- Benjamini, 2001, Controlling the false discovery rate in behavior genetics research, Behav Brain Res, 125, 279, 10.1016/S0166-4328(01)00297-2 · DOI · Paper page
- Munoz, 2009, New imputation methods for missing data using quantiles, J Comput Appl Math, 232, 305, 10.1016/j.cam.2009.06.011 · DOI
- Simon, 2007, Analysis of gene expression data using BRB-ArrayTools, Cancer Inform, 3, 11, 10.1177/117693510700300022 · DOI · Paper page
- Nieminen, 2009, Molecular analysis of endometrial tumorigenesis: importance of complex hyperplasia regardless of atypia, Clin Cancer Res, 15, 5772, 10.1158/1078-0432.CCR-09-0506 · DOI
- Shivapurkar, 2007, Evaluation of candidate methylation markers to detect cervical neoplasia, Gynecol Oncol, 107, 549, 10.1016/j.ygyno.2007.08.057 · DOI
- Takai, 2001, Silencing of HTR1B and reduced expression of EDN1 in human lung cancers, revealed by methylation-sensitive representational difference analysis, Oncogene, 20, 7505, 10.1038/sj.onc.1204940 · DOI
- Archer, 2010, High-throughput assessment of CpG site methylation for distinguishing between HCV-cirrhosis and HCV-associated hepatocellular carcinoma, Mol Genet Genom, 283, 341, 10.1007/s00438-010-0522-y · DOI
- Sousa, 2011, Methylation of cancer-stem-cell-associated Wnt target genes predicts poor prognosis in colorectal cancer patients, Cell Stem Cell, 9, 476, 10.1016/j.stem.2011.10.008 · DOI · Paper page
- Cohen, 2010, Pituitary adenylyl cyclase activating polypeptide inhibits gli1 gene expression and proliferation in primary medulloblastoma derived tumorsphere cultures, BMC Cancer, 10, 676, 10.1186/1471-2407-10-676 · DOI
- Zhang, 2011, The neuropeptide Y system: pathophysiological and therapeutic implications in obesity and cancer, Pharmacol Ther, 131, 91, 10.1016/j.pharmthera.2011.03.011 · DOI · Paper page
- Zhang, 2012, NPY modulates PYY function in the regulation of energy balance and glucose homeostasis, Diabetes Obes Metab, 14, 727, 10.1111/j.1463-1326.2012.01592.x · DOI
- Torres, 2012, Risk factors for developing endometrial cancer after benign endometrial sampling, Obstet Gynecol, 120, 998, 10.1097/AOG.0b013e31826b9fef · DOI
- Evans, 2011, Differential trends in the rising incidence of endometrial cancer by type: data from a UK population-based registry from 1994 to 2006, Br J Cancer, 104, 1505, 10.1038/bjc.2011.68 · DOI · Paper page
- Widschwendter, 2004, Analysis of aberrant DNA methylation and human papillomavirus DNA in cervicovaginal specimens to detect invasive cervical cancer and its precursors, Clin Cancer Res, 10, 3396, 10.1158/1078-0432.CCR-03-0143 · DOI
- Wu, 2000, Endometrial brush biopsy (Tao brush). Histologic diagnosis of 200 cases with complementary cytology: an accurate sampling technique for the detection of endometrial abnormalities, Am J Clin Pathol, 114, 412, 10.1093/ajcp/114.3.412 · DOI
- Wentzensen, 2013, From differences in means between cases and controls to risk stratification: a business plan for biomarker development, Cancer Discov, 3, 148, 10.1158/2159-8290.CD-12-0196 · DOI
Cited by
Association of Endometrial Cancer Risk With Postmenopausal Bleeding in Women
Clarke, M. A., Long, B. J., Del Mar Morillo, A., Arbyn, M., Bakkum-Gamez, J. N., & Wentzensen, N. (2018) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2018.2820 · Cited by 426
Self-citationDetection of endometrial cancer via molecular analysis of DNA collected with vaginal tampons.
Bakkum-Gamez, J. N., Wentzensen, N., Maurer, M. J., Hawthorne, K. M., Voss, J. S., Kroneman, T. N., Famuyide, A. O., Clayton, A. C., Halling, K. C., Kerr, S. E., et al. (2015) · Gynecologic Oncology · doi:10.1016/j.ygyno.2015.01.552 · Cited by 107
“Details on the discovery effort to identify these abnormally methylated genes and the affected CpG sites have been previously reported (34).”
BackgroundMethodInfluentialSelf-citationNeal, A. S., Nunez, M., Lai, T., Tosevska, A., Morselli, M., Amneus, M., Zakhour, M., Moatamed, N. A., Pellegrini, M., & Memarzadeh, S. (2020) · Reproductive Sciences · doi:10.1007/s43032-020-00175-w · Cited by 11
“Although the epigenetic landscape has been investigated in endometrial cancer [20 – 24], there is limited analysis independently examining epithelial and stromal compartments.”
Metadata
- Authors
- Wentzensen, N., Bakkum-Gamez, J. N., Killian, J. K., Sampson, J., Guido, R., Glass, A., Adams, L., Luhn, P., Brinton, L. A., Rush, B., d'Ambrosio, L., Gunja, M., Yang, H. P., Garcia-Closas, M., Lacey, J. V., Lissowska, J., Podratz, K., Meltzer, P., Shridhar, V., & Sherman, M. E.
- Venue
- International Journal of Cancer
- Publisher
- Wiley
- Published
- 2014-03-31
- Volume
- 135
- Issue
- 8
- Pages
- 1860-1868
- ISSN
- 0020-7136 (ISSN-L)
- OpenAlex
- W1607675287
- Cited by
- 77
- References
- 3
- FWCI
- 2.31
- Type
- journal article
- Language
- en
- Open access
- green
- Licence
- doi.wiley.com/10.1002/tdm_license_1.1 (tdm, 519 d)
- Funders
- National Institutes of Health (ZIA CP010126-14)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.